Effects of nitroglycerin treatment on baroreflex sensitivity and short-term heart rate variability in humans

Journal of the American College of Cardiology

Volumn 40, Issue 11, 2002, Pages 2000-2005

  Gori, Tommaso ^a   Floras, John S ^a   Parker, John D ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERYL TRINITRATE; NITRIC OXIDE;

ADRENERGIC SYSTEM; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MONITORING; CALCULATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFECT; DRUG TOLERANCE; FOURIER TRANSFORMATION; HEART FAILURE; HEART RATE VARIABILITY; HUMAN; MALE; NONHUMAN; NORMAL HUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PROGNOSIS; RR INTERVAL; STATISTICAL SIGNIFICANCE; SYMPATHETIC NERVE; SYSTOLIC BLOOD PRESSURE; VAGUS NERVE STIMULATION;

ADOLESCENT; ADULT; BAROREFLEX; BLOOD PRESSURE; COMPARATIVE STUDY; ELECTROCARDIOGRAPHY; HEART RATE; HUMAN; MALE; NITROGLYCERIN; OBSERVER VARIATION; PARASYMPATHETIC NERVOUS SYSTEM; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SUPPORT, NON-U.S. GOV'T; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 0037021519     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)02532-9     Document Type: Article

References (30)

1. Parker JD, Farrell B, Fenton T, Cohanim M, Parker JO. Counterregulatory responses to continuous and intermittent therapy with nitroglycerin. Circulation 1991;84:2336-45.
2. Dupuis J, Lalonde G, Lemieux R, Rouleau JL. Tolerance to intravenous nitroglycerin in patients with congestive heart failure: Role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine. J Am Coll Cardiol 1990;16:923-31.
3. Ma SX, Schmid PG Jr, Long JP. Noradrenergic mechanisms and the cardiovascular actions of nitroglycerin. Life Sci 1994;55:1595-603.
4. Zanzinger J, Czachurski J, Seller H. Inhibition of sympathetic vasoconstriction is a major principle of vasodilation by nitric oxide in vivo. Circ Res 1994;75:1073-7.
5. Harada S, Tokunaga S, Momohara M, et al. Inhibition of nitric oxide formation in the nucleus tractus solitarius increases renal sympathetic nerve activity in rabbits. Circ Res 1993;72:511-6.
6. Hansen J, Jacobsen TN, Victor RG. Is nitric oxide involved in the tonic inhibition of central sympathetic outflow in humans? Hypertension 1994;24:439-44.
7. Schwarz P, Diem R, Dun NJ, Forstermann U. Endogenous and exogenous nitric oxide inhibits norepinephrine release from rat heart sympathetic nerves. Circ Res 1995;77:841-8.
8. Chowdhary S, Vaile JC, Fletcher J, Ross HF, Coote JH, Townend JN. Nitric oxide and cardiac autonomic control in humans. Hypertension 2000;36:264-9.
9. Chowdhary S, Townend JN. Role of nitric oxide in the regulation of cardiovascular autonomic control. Clin Sci 1999;97:5-17.
10. Zanzinger J, Czachurski J, Seller H. Impaired modulation of sympathetic excitability by nitric oxide after long-term administration of organic nitrates in pigs. Circulation 1998;97:2352-8.
11. Lorenzi-Filho G, Dajani HR, Leung RST, Floras JS, Bradley TD. Entrainment of blood pressure and heart rate oscillations by periodic breathing. Am J Respir Crit Cate Med 1999;159:1147-54.
12. Butler GC, Senn BL, Floras JS. Influence of atrial natriuretic factor on spontaneous baroreflex sensitivity for heart rate in humans. Hypertension 1995;25:1167-71.
13. Parlow J, Viale JP, Annat G, Hughson R, Quintin L. Spontaneous cardiac baroreflex in humans: Comparison with drug-induced responses. Hypertension 1995;25:1058-68.
14. Mancia G, Mark A. Arterial baroreflexes in humans. In: Shepherd JT, Abboud FM, editors. Handbook of Physiology, Section 2: The Cardiovascular System, Volume III, Peripheral Circulation and Organ Blood Flow. Washington, DC: American Physiological Society, 1983:755-94.
15. Task Force of the European Society of Cardiology the North American Society of Pacing Electrophysiology. Heart rate variability: Standards of measurement, physiological interpretation, and clinical use. Circulation 1996;93:1043-65.
16. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 1991;84:482-92.
17. Eckberg DL. Sympathovagal balance: A critical appraisal. Circulation 1997;96:3224-32.
18. Gori T, Mak S, Kelly S, Parker JD. Evidence supporting abnormalities in nitric oxide synthase function induced by nitroglycerin in humans. J Am Coll Cardiol 2001;38:1096-101.
19. Stewart DJ, Elsner D, Sommer O, Holtz J, Bassenge E. Altered spectrum of nitroglycerin action in long-term treatment: Nitroglycerinspecific venous tolerance with maintenance of arterial vasodepressor potency. Circulation 1986;74:573-82.
20. Pomeranz B, Macaulay RJ, Caudill MA, et al. Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol 1985;248:H151-3.
21. La Rovere MT Bigger JT Jr., Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction: ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) investigators. Lancet 1998;351:478-84.
22. Osterziel KJ, Hanlein D, Willenbrock R, Eichhorn C, Luft F, Dietz R. Baroreflex sensitivity and cardiovascular mortality in patients with mild to moderate heart failure. Br Heart J 1995;73:517-22.
23. Matsuda T, Bates JN, Lewis SJ, Abboud FM, Chapleau MW. Modulation of baroreceptor activity by nitric oxide and S-nitrosocysteine. Circ Res 1995;76:426-33.
24. Zanzinger J, Czachurski J, Seller H. Lack of nitric oxide sensitivity of carotid sinus baroreceptors activated by normal blood pressure stimuli in cats. Neurosci Lett 1996;208:121-4.
25. Hogan N, Kardos A, Paterson DJ, Casadei B. Effect of exogenous nitric oxide on baroreflex function in humans. Am J Physiol 1999;277: H221-7.
26. Kelly RP, Gibbs HH, O'Rourke MF, et al. Nitroglycerin has more favourable effects on left ventricular afterload than apparent from measurement of pressure in a peripheral artery. Eur Heart J 1990;11:138-44.
27. Smith-White MA, Wallace D, Potter EK. Sympathetic-parasympathetic interactions at the heart in the anaesthetized rat. J Auton Nerv Syst 1999;75:171-5.
28. Parker JD, Parker AB, Farrell B, Parker JO. The effect of hydralazine on the development of tolerance to continuous nitroglycerin. J Pharmacol Exp Ther 1997;280:866-75.
29. Munzel T, Kurz S, Rajagopalan S, et al. Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase: A new action for an old drug. J Clin Invest 1996;98:1465-70.
30. Zanzinger J. Role of nitric oxide in the neural control of cardiovascular function. Cardiovasc Res 1999;43:639-49.